Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
alteminostat (CKD-581) / Chong Kun Dang
NCT03051841: CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma	Recruiting	1	18	RoW	CKD-581, CKD-581 bortezomib dexamethasone regimen	Chong Kun Dang Pharmaceutical	Myeloma, Multiple	04/21	11/22